OIG: Medicare Advantage plans denying, delaying services to beneficiaries … FDA approves first drug in its class to treat the heart ailment obstructive HCM … Intranasal insulin may boost function in seniors with, without type 2 diabetes: study … Big pharma in race to bring ‘blockbuster’ obesity drugs to more patients … Southern states account for an outsized number of COVID-19 deaths
Clinical briefs for Monday, May 2
May 2, 2022